- Home
- LI vs ASND Comparison
LI vs ASND Comparison
Compare LI & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | ASND |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | China | Denmark |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 13.6B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | LI | ASND |
|---|---|---|
| Price | $17.81 | $229.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 15 |
| Target Price | $20.46 | ★ $278.80 |
| AVG Volume (30 Days) | ★ 2.2M | 718.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $98.02 |
| Revenue Next Year | $19.97 | $43.13 |
| P/E Ratio | $29.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.71 | $124.06 |
| 52 Week High | $32.03 | $248.60 |
Technical Indicators
Market Signals| Indicator | LI | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 50.54 | 49.46 |
| Support Level | $17.59 | $190.49 |
| Resistance Level | $19.05 | $245.30 |
| Average True Range (ATR) | 0.43 | 9.40 |
| MACD | -0.02 | -0.89 |
| Stochastic Oscillator | 53.90 | 35.92 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.